Malnutrition is common in patients with chronic obstructive pulmonary disease (COPD), particularly as the disease progresses. This article looks at the nutritional issues facing patients with COPD, including the effects of medication, social and psychological issues. It outlines the role that general practice nurses (GPNs) can play by implementing the newly updated ‘Managing Malnutrition in COPD’ guidance. The guidance encourages incorporation of nutritional screening into COPD care pathways and the optimisation of nutritional intake for those at medium and high risk of malnutrition via dietary advice and oral nutritional supplementation, where appropriate. It also provides practical tips for patients with COPD to help manage common barriers to eating, such as shortness of breath, dry mouth and taste changes.
In December 2018, the National Institute for Health and Care Excellence (NICE) published new guidelines on the diagnosis and management of chronic obstructive pulmonary disease (COPD) in over 16s, which have subsequently been updated in July 2019 (NICE, 2019). Here, Jaqui Walker, advanced nurse practitioner/general practice nurse, Stirling, looks at what the 2019 changes are, how they are influencing practice, and gives handy tips on how to implement the key changes.
Nutrition is an important modifiable factor for patients with chronic obstructive pulmonary disease (COPD). Being overweight brings breathing difficulties and being malnourished leads to poorer outcomes. Maintaining a healthy weight and a nutritious diet is a central part of COPD management. This article equips general practice nurses (GPNs) and patients with the tools needed to assess and promote a healthy weight and diet while living with COPD. It explains the reasons for malnutrition and how these can be avoided. Helping people improve their diet as well as the role of oral nutritional supplements (ONS) are explored, and specific issues, such as vitamin D deficiency, are discussed.
Supporting patients with COPD to self-care.
By 2030, chronic obstructive pulmonary disease (COPD) is projected to be the third leading cause of death worldwide (World Health Organization [WHO], 2016). Within the UK, it is estimated that around three million people are living with COPD in England alone, with two million of these unaware that they are living with the condition (Department of Health [DH], 2012).
It is the fifth biggest killer in the UK overall, causing about 30,000 deaths each year (DH, 2011). The condition itself is associated with considerable disability, impaired quality of life and high utilisation of healthcare resources.